Suppression of Glypican 3 Inhibits Growth of Hepatocellular Carcinoma Cells through Up-Regulation of TGF-β2

by Chris K. Sun, Mei-Sze Chua, Jing He, K. So Samuel
Published 2011-08-01

Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma

by Brian J. Peter, Samuel So, Dorothy Yang, Anya Tsalenko, Mei-Sze Chua, Hongbo Sun
Published 2008-01-01

Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma

by Hongbo Sun, Mei-Sze Chua, Dorothy Yang, Anya Tsalenko, Brian J. Peter, Samuel So
Published 2008-01-01

Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets

by Bin Chen, Li Ma, Hyojung Paik, Marina Sirota, Wei Wei, Mei-Sze Chua, Samuel So, Atul J. Butte
Published 2017-07-01

A Humanized Anti-GPC3 Antibody for Immuno-Positron Emission Tomography Imaging of Orthotopic Mouse Model of Patient-Derived Hepatocellular Carcinoma Xenografts

by Arutselvan Natarajan, Hui Zhang, Wei Ye, Lakshmi Huttad, Mingdian Tan, Mei-Sze Chua, Sanjiv S. Gambhir, Samuel K. So
Published 2021-08-01

Molecular Imaging of Hepatocellular Carcinoma Xenografts with Epidermal Growth Factor Receptor Targeted Affibody Probes

by Ping Zhao, Xiaoyang Yang, Shibo Qi, Hongguang Liu, Han Jiang, Susan Hoppmann, Qizhen Cao, Mei-Sze Chua, Samuel K. So, Zhen Cheng
Published 2013-01-01

Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker.

by Albert Y Lin, Mei-Sze Chua, Yoon-La Choi, William Yeh, Young H Kim, Raymond Azzi, Gregg A Adams, Kristin Sainani, Matt van de Rijn, Samuel K So, Jonathan R Pollack
Published 2011-02-01